Spanish-speaking families with leukemia or lymphoma
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study aims to improve communication and strengthen a child’s “medical home” (the main care team and coordination) for Spanish-speaking families. It focuses on families receiving cancer care at the Center for Cancer and Blood Disorders (CCBD).
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 0 and 22 years old
- The child has leukemia or non-Hodgkin lymphoma
- Spanish is the preferred language for the patient or a parent/guardian
- You receive (or received) cancer care at the Center for Cancer and Blood Disorders (CCBD)
- The child’s care is not only outside CCBD
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a storybook explaining childhood leukemia helps reduce stress for parents, compared to the usual support. It may help parents of newly diagnosed children feel more prepared and less anxious.
This study looks at whether LLS services and support improve outcomes and the day-to-day experience of care for people with leukemia, lymphoma, myeloma, MDS, or MPN. It’s mainly about matching you to the right support and following your progress for 6 months.
This study creates and tests Spanish educational videos for parents of children with cancer. It aims to help Spanish-speaking families better understand their child's cancer care.
This study is for young adult childhood cancer survivors who are Hispanic or Latino. It tests a program that brings families together to help you communicate about survivorship care.
This trial studies how screening for social needs (like housing, food, or transportation) and offering early help can improve care for adults with leukemia. It is for patients newly referred to a leukemia clinic.
This study tests an approach for discussing and sharing what patients value about their health, and adapting it for Latinx communities. It involves separate interviews with patients, families/caregivers, and oncology clinicians to improve how the intervention works and is understood.
Hear when a new Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.